Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Novavax Inc. (NVAX)

NASDAQ

$9.23

$--

(0.00%)

Pre-Market

Novavax Inc. (NVAX) Live Price Chart

Last updated: ⁦2026-09-16 09:04:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Novavax Inc. (NVAX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $9.23, with a market capitalisation of $1.58B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.20 to $11.97. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.58B
Open	$9.23
Day's High	$331.68
Day's Low	$3.53
Previous Close	$9.23
Volume	3.65K
Average Volume	4.34M
P/E Ratio	--
52-Week High	$11.97
52-Week Low	$6.20
Dividend Yield	--
Earnings Date	--

Novavax Inc. (NVAX) Pre-Market Stock Price

Novavax Inc. (NVAX) is trading at $9.23 in pre-market trading as of 2026-09-16 09:01:00, down 0.05% ($0.01) from the previous close of $9.23

Pre-market trading shows how investors are pricing NVAX before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Novavax Inc. (NVAX) 7-Day Stock Price Change

Over the past seven days, Novavax Inc. (NVAX) moved from $10.22 to $9.23, representing a decline of 9.74% ($1.00).

The stock traded between $9.11 and $10.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 4.64 million shares, down versus the previous seven-day period, indicating lower trading activity.

NVAX 52-Week Price Position

Position in Range: 52.4%

52W Low$6.20

52W High$11.97

NVAX is currently trading at $9.23, placing it 52.4% of the way from its 52-week low of $6.20 to its 52-week high of $11.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Novavax Inc. (NVAX)?

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Novavax Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	749
Exchange	NASDAQ
Company Website	https://www.novavax.com

How to Buy Novavax Inc. (NVAX) Stock on MEXC

Eligible investors can buy real shares of Novavax Inc. (NVAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NVAX and Place Your Order

Open the RealStocks trading page and search for NVAX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Novavax Inc. (NVAX) stock price today?

Novavax Inc. (NVAX) is currently trading at $ 9.23, down 0.05% ($0.01) from the previous close of $ 9.23. Intraday prices update in real time during regular trading hours.

2.Is NVAX stock going up or down today?

As of 2026-09-16 09:01:00, NVAX is trading at $ 9.23, down 0.05% ($0.01) from its previous close of $ 9.23. The stock has traded between $ 3.53 and $ 331.68 during today’s regular session. Past price movements do not guarantee future results.

3.What is NVAX pre-market price?

As of 2026-09-16 09:01:00, NVAX is trading at $ 9.23 in pre-market trading, down 0.05% ($0.01) from the previous close of $ 9.23. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NVAX after-hours price?

As of 2026-09-16 09:01:00, NVAX is trading at $ 9.22 in after-hours trading, down 0.07% ($0.01) from the regular-session close of $ 9.23. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NVAX stock trading now?

NVAX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NVAX sit relative to its 52-week high and low?

Over the past 52 weeks, NVAX has traded between a low of $ 6.20 and a high of $ 11.97. At $ 9.23, the stock is positioned 52.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Novavax Inc. in?

Novavax Inc. (NVAX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Novavax Inc.'s market capitalisation and where is it listed?

Novavax Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.58B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NVAX valued in terms of P/E ratio and EPS?

NVAX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.50. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Novavax Inc. pay a dividend?

Novavax Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.